Adaptive Research Appoints Mark Tsuchiyose, MD as Vice President, Clinical Affairs and Therapeutic Head, Gastroenterology, and Dhira Khosla, DO as Vice President, Strategic Clinical Partnerships, Positioning Company to Drive Continued Growth
SAN FRANCISCO, March 16, 2021 (GLOBE NEWSWIRE) -- Adaptive Research Inc. (the “Company”), a healthcare ecosystem that enables community physicians to participate in clinical trials, thereby improving in-need patient access to innovative investigational agents or technologies under development while expanding access to a larger eligible patient pool for biotechnology and pharmaceutical Sponsors, today announced that Mark Tsuchiyose, MD and Dhira Khosla, DO have joined the executive team as Vice President, Clinical Affairs and Therapeutic Head, Gastroenterology, and Vice President, Strategic Clinical Partnerships, respectively.Dr. Tsuchiyose will lead the growth and expansion of the Company’s core businesses and identify other leaders in the field to enhance Adaptive Research mission. Dr. Tsuchiyose is a graduate from University of Southern California School of Medicine in 1983. He completed his Internal Medicine residency at Huntington Memorial Hospital in Pasadena, California and a gastroenterology fellowship at LAC/USC Medical Center. During his 25 years of practice, Dr. Tsuchiyose has been an Associate Clinical Professor at the University of California, San Francisco and a Section Chief in the division of Gastroenterology at Seton Medical Center and served as Chairman of Medicine.Dr. Khosla will lead the Company’s clinical strategic partner initiatives with the business development team. Dr. Khosla is an alumnus of the Philadelphia College of Osteopathic Medicine, completing her neurology residency at SUNY and fellowship in Electromyography and Neuromuscular at Stanford University. As a practicing physician, Dr. Khosla founded a private practice and served as a physician consultant and Principal Investigator for several organizations in the San Francisco Bay Area.“As we look towards 2021, I am pleased to announce the appointment of Dr. Tsuchiyose and Dr. Khosla to expand our current capabilities and offering to biotechnology and pharmaceutical Sponsors. Their respective leadership will be crucial to the successful growth of Adaptive Research,” stated Deepak Behera, MD, President and Chief…